299 related articles for article (PubMed ID: 8111817)
1. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
Nifedipine-Atenolol Study Review Committee
Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
[TBL] [Abstract][Full Text] [Related]
5. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
Harder S; Rietbrock S; Thürmann P
Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group.
Leon AS
Clin Ther; 1993; 15(6):1094-107. PubMed ID: 8111807
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
10. Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension.
Clamp M; Holmes B; Wilcox R
J Hum Hypertens; 1990 Oct; 4(5):557-63. PubMed ID: 2283646
[TBL] [Abstract][Full Text] [Related]
11. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
Zanchetti A
J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension.
Edwards KG; Tweed JA; Saul PA; Wright FW
Pharmatherapeutica; 1986; 4(10):637-41. PubMed ID: 3602015
[TBL] [Abstract][Full Text] [Related]
13. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
Kraft K; Schiessl S; Vetter H
Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
16. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension in the very old.
Otterstad JE; Ruilope LM
Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension.
Smith DH; Neutel JM; Jankelow D; Pretorius JJ; Myburgh DP
S Afr Med J; 1991 Jan; 79(1):12-5. PubMed ID: 1986440
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
Toal CB
Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
[TBL] [Abstract][Full Text] [Related]
20. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
